Sage Journals: Discover world-class research

Open access

Research article

First published 2012

Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)

Krupa S. Jani, D.S. Dalafave

Bioinformatics and Biology Insights

Retricted access

Research article

First published 2007-12

Development and Implementation of a Miniaturized High-Throughput Time-Resolved Fluorescence Energy Transfer Assay to Identify Small Molecule Inhibitors of Polo-Like Kinase 1

Elizabeth R. Sharlow, Stephanie Leimgruber, Tong Ying Shun [...]

ASSAY and Drug Development Technologies

Retricted access

Research article

First published 2010-02

Multiplexed Random Peptide Library and Phospho-Specific Antibodies Facilitate Human Polo-Like Kinase 1 Inhibitor Screen

Kenji Tanaka, Mitsunori Koresawa, Masato Iida [...]

ASSAY and Drug Development Technologies

Open access

Research article

First published 2020-5

BI6727,a polo-like kinase 1 inhibitor with promising efficacy on Burkitt lymphoma cells

Er Chen, Renzhi Pei

Journal of International Medical Research

Free access

Review article

First published 2015-4

Targeting polo-like kinase 1 in acute myeloid leukemia

Joseph M. Brandwein

Therapeutic Advances in Hematology

Free access

Research article

First published 2020-4

Antiviral Activity of PLK1-Targeting siRNA Delivered by Lipid Nanoparticles in HBV-Infected Hepatocytes

Adrien Foca, Ammen Dhillon, Thomas Lahlali [...]

Antiviral Therapy

Retricted access

Research article

First published 2018-08

High-Throughput Screening Identifies Kinase Inhibitors That Increase Dual Adeno-Associated Viral Vector Transduction In Vitro and in Mouse Retina

Andrea Maddalena, Fabio Dell'Aquila, Pia Giovannelli [...]

Human Gene Therapy

Retricted access

Research article

First published 2013-09

Inhibition of Polo-Like Kinase 1 Induces Cell Cycle Arrest and Sensitizes Glioblastoma Cells to Ionizing Radiation

Julia Alejandra Pezuk, María Sol Brassesco, Andressa Gois Morales [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2013-10

The PLK1 Inhibitor GSK461364A Is Effective in Poorly Differentiated and Anaplastic Thyroid Carcinoma Cells,Independent of the Nature of Their Driver Mutations

Marika A. Russo, Kristy S. Kang, Antonio Di Cristofano

Thyroid®

Search results